Towards an ideal biomaterial for vitreous replacement: Historical overview and future trends

Acta Biomaterialia

Volumn 7, Issue 3, 2011, Pages 921-935

  Baino, Francesco ^a  

^a POLITECNICO DI TORINO   (Italy)

Author keywords

Hydrogels; Perfluorocarbons; Retinal detachment; Silicone oil; Vitreous substitution

Indexed keywords

BIOMATERIALS; CLINICAL RESEARCH; OPHTHALMOLOGY; SILICONES;

'CURRENT; CLINICAL USE; FUTURE TRENDS; PERFLUOROCARBONS; POLYMERIC HYDROGELS; RETINAL DETACHMENTS; SILICONE OIL; VITREOUS BODY; VITREOUS SUBSTITUTE; VITREOUS SUBSTITUTION;

HYDROGELS;

BIOMATERIAL; COLLAGEN; FLUOROCARBON; GELATIN; HYALURONIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; POLOXAMER; POLY(2 HYDROXYETHYL ACRYLATE; POLY(METHYL 2 ACRYLAMIDOGLYCOLATE METHYL ETHER); POLY(VINYL ALCOHOL METHACRYLATE); POLYACRYLAMIDE; POLYGLYCERYL METHACRYLATE HYDROGEL; POLYMACON; POLYMER; POLYSACCHARIDE; POLYVINYL ALCOHOL; POVIDONE; SILICONE; SULFUR HEXAFLUORIDE; UNCLASSIFIED DRUG;

AGING; AQUEOUS HUMOR; ARTICLE; CHEMICAL COMPOSITION; CROSS LINKING; EMBRYO DEVELOPMENT; HUMAN; HYDROGEL; IMPLANT; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REFRACTION INDEX; RETINA DETACHMENT; VISCOSITY; VITRECTOMY; VITREOUS BODY; VITREOUS BODY DETACHMENT;

EID: 79251642205     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.10.030     Document Type: Review

References (193)

1. B.P. Gloor The vitreous R.A. Moses, W.M. Hart, Adler's physiology of the eye 1987 CV Mosby Co. St. Louis 246 267
2. J. Sebag Macromolecular structure of the corpus vitreus Prog Polym Sci 23 1998 415 446
3. T.V. Chirila, and Y. Hong The vitreous humour J. Black, G.W. Hastings, Handbook of biomaterial properties 1998 Chapman & Hall London 125 131
4. J.G.F. Worst, and L.I. Los Cisternal anatomy of the vitreous 1995 Kugler Publications Amsterdam
5. Ponsioen TL, Hooymans JMM, Los LI. Remodelling of the human vitreous and vitreoretinal interface - a dynamic process. Prog Retinal Eye Res, in press. doi:10.1016/j.preteyeres.2010.07.001.
6. M.M. Le Goff, and P.N. Bishop Adult vitreous structure and postnatal changes Eye 22 2008 1214 1222
7. A.V. Noulas, S.S. Skandalis, E. Feretis, D.A. Theocharis, and N.K. Karamanos Variations in content and structure of glycosaminoglycans of the vitreous gel from different mammalian species Biomed Chromatogr 18 2004 457 461
8. P.N. Bishop Structural macromolecules and supramolecular organisation of the vitreous gel Prog Retinal Eye Res 19 2000 323 344
9. R.L. Zimmerman In vivo measurements of the viscoelasticity of the human vitreous humor Biophys J 29 1980 539 544
10. B. Lee, M. Litt, and G. Buchsbaum Rheology of the vitreous body. Part I: Viscoelasticity of human vitreous Biorheology 29 1992 521 533
11. C.S. Nickerson, J. Park, J.A. Kornfield, and H. Karageozian Rheological properties of the vitreous and the role of hyaluronic acid J Biomech 41 2008 1840 1846
12. W.L. Jongebloed, and J.F. Worst The cisternal anatomy of the vitreous body Doc Ophthalmol 63 1987 183 196
13. N.E. Byer Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment Ophthalmology 101 1994 1503 1514
14. L.I. Los, R.J. Van Der Vorp, M.J.A. Van Luyn, and J.M.M. Hooymans Age-related liquefaction of vitreous body: LM and TEM evaluation of the role of proteoglycans and collagen Invest Ophthalmol Vis Sci 44 2003 2828 2833
15. J.Y. Chuo Risk factors for posterior vitreous detachment: a case-control study Am J Ophthalmol 142 2006 931 937
16. M. Diaz-Llopis, and E. Cervera Posterior vitreous detachment and pharmacological vitreolysis: the new age of enzymatic vitrectomy Arch Soc Esp Oftalmol 82 2007 465 466
17. M.W. Johnson Posterior vitreous detachment: evolution and complications of its early stages Am J Ophthalmol 149 2010 371 382
18. D.J. D'Amico Medical progress - diseases of the retina N Engl J Med 331 1994 95 106
19. T.A. Ciulla, R.P. Danis, and A. Harris Age-related macular degeneration: a review of experimental treatments Surv Ophthalmol 43 1998 134 146
20. D.A. Brinton, and C.P. Wilkinson Retinal detachment - principles and practice 2009 Oxford University Press Oxford, UK
21. P.A. Cibis Vitreoretinal pathology and surgery in retinal detachment 1965 CV Mosby Co. St. Louis
22. D.G. Fuller, and W.L. Hutton Presurgical evaluation of eyes with opaque media 1982 Grune & Stratton New York
23. N. Holekamp The vitreous gel: more than meets the eye Am J Ophthalmol 149 2010 32 36
24. R. Machemer The development of pars plana vitrectomy: a personal account Graefes Arch Clin Exp Ophthalmol 233 1995 453 468
25. G.F. Hilton, and W.S. Grizzard Pneumatic retinopexy: a two-step outpatient operation without conjunctival incision Ophthalmology 93 1986 626 641
26. P.E. Tornambe Pneumatic retinopexy: the evolution of case selection and surgical technique. A twelve-year study of 302 eyes Trans Am Ophthalmol Soc 95 1997 551 578
27. T.V. Chirila, S. Tahija, Y. Hong, S. Vijayasekaran, and I.J. Constable Synthetic polymers as materials for artificial vitreous body: review and recent advances J Biomater Appl 9 1994 121 137
28. T.V. Chirila, Y. Hong, P.D. Dalton, I.J. Constable, and M.F. Refojo The use of hydrophilic polymers as artificial vitreous Prog Polym Sci 23 1998 475 508
29. J. Sebag The vitreous - structure, function and pathobiology 1989 Springer New York
30. Laude A, Tan LE, Wilson CG, Lascaratos G, Elashry M, Aslam T, et al. Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics. Prog Ret Eye Res, in press. doi:10.1016/j.preteyeres.2010.04.003.
31. R. Deutschmann Zur Operativen Behandlung der Netzhautablosung Klein Monastbl Augenheilkd 44 1906 364 370
32. N.L. Cutler Vitreous transplantation Trans Am Acad Ophthalmol Otolaryngol 52 1947 253 259
33. D.M. Shafer, and J.L. Bussey Further experience with vitreous implants in old retinal detachments Arch Ophthalmol 60 1958 255 257
34. J. Ohm Ueber die Behandlung der Netzhautablosung durch operative Entleerung der subretinalen Flussigkeit und Einspiritzung von Luft in den Glaskorper Graefes Arch Clin Ophthalmol 79 1911 442 450
35. B. Rosengren Results of treatment of detachment of the retina with diathermy and injection of air into the vitreous Acta Ophthalmol 16 1938 573 579
36. E.W.D. Norton, T. Aaberg, W. Fung, and V.T. Curtin Giant retinal tears. I. Clinical management with intravitreal air Trans Am Ophthalmol Soc 67 1969 374 393
37. D.M. Marcus, D.J. D'Amico, and S. Mukai Pneumatic retinopexy versus scleral buckling for repair of primary rhegmatogenous retinal detachment Int Ophthalmol Clin 34 1994 97 108
38. P.V. Algvere, M. Gjotterberg, G. Olivestedt, and S. Fituri Results of pneumatic retinopexy with air Acta Ophthalmol 70 1992 632 636
39. J. Sebag, and M. Tang Pneumatic retinopexy using only air Retina 13 1993 8 12
40. D. Wong, R.L. Williams, and M.J. German Exchange of perfluorodecalin for gas or oil: a model for avoiding slippage Graefes Arch Clin Exp Ophthalmol 236 1998 234 237
41. C. Gilbert, and D. McLeod D-ACE surgical sequence for selected bullous retinal detachments Br J Ophthalmol 69 1985 733 736
42. E.W.D. Norton Intraocular gas in the management of selected retinal detachments Trans Am Acad Ophthalmol Otolaryngol 77 1973 85 98
43. H.A. Lincoff, J. Mardirossian, A. Lincoff, P. Ligget, T. Iwamoto, and F. Jakobiec Intravitreal longevity of three perfluorocarbon gases Arch Ophthalmol 98 1980 1610 1611
44. H. Lincoff, J.M. Maisel, and A. Lincoff Intravitreal disappearance rates of four perfluorocarbon gases Arch Ophthalmol 102 1984 928 929
45. S. Chang, H. Lincoff, D.J. Coleman, W. Fuch, and M. Farber Perfluorocarbon gases in vitreous surgery Ophthalmology 92 1985 651 656
46. J.J. Crittenden, E. De Juan, and J. Tiedeman Expansion of long-acting gas bubbles for intraocular use Arch Ophthlamol 103 1985 831 834
47. D.L. Van Horn, H.F. Edelhauser, T.M. Aaberg, and H.J. Pederson In vivo effects of air and sulphur hexafluoride gas on rabbit corneal endothelium Invest Ophthalmol 11 1972 1028 1036
48. H. Juzoji, T. Iwasaki, M. Usui, M. Hasemi, and N. Yamakawa Histological study of intraocular changes in rabbits after intravitreal gas injection Jpn J Ophthalmol 41 1997 278 283
49. J.S. Lean, D.C. Boone, S.P. Azen, M.Y. Lai, K.L.P. Linton, and B. McCuen Silicone Study Group: Vitrectomy with silicone oil or sulphur hexafluoride gas in eyes with severe proliferative vitreoretinopathy. Results of a randomized clinical trial (Silicone Study Report No. 1) Arch Ophthalmol 110 1992 770 779
50. B. McCuen, S.P. Azen, D.C. Boone, M.Y. Lai, K.L.P. Linton, and J. Lean Silicone Study Group: Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Results of a randomized clinical trial (Silicone Study Report No. 2) Arch Ophthalmol 110 1992 780 792
51. I.J. Constable, and D.A. Swann Vitreous substitution with gases Arch Ophthalmol 93 1975 416 419
52. J.T. Thompson The absorption of mixtures of air and perfluoropropane after pars plana vitrectomy Arch Ophthalmol 110 1992 1594 1597
53. 6) in the treatment of rhegmatogenous retinal detachment Arch Ophthalmol 110 1992 1723 1724
54. T.S. Chang, C.D. Pelzek, R.L. Nguyen, S.S. Purohit, G.R. Scott, and D. Hay Inverted pneumatic retinopexy: a method of treating retinal detachments associated with inferior retinal breaks Ophthalmology 110 2003 589 594
55. A. Lincoff, H. Lincoff, C. Solorzano, and T. Iwamoto Selection of xenon gas for rapidly disappearing retinal tamponade Arch Opthalmol 100 1982 996 997
56. H. Lincoff, and I. Kreissig Applications of xenon gas to clinical retinal detachment Arch Ophthalmol 100 1982 1083 1085
57. A. Elschnig Uber Glaskorperersatz: II. Teil Graefes Arch Ophthalmol 80 1912 514 536
58. D.J. Wood Detached retina Br J Ophthalmol 4 1920 413 415
59. E.G. Grafton, and J.S. Guyton The value of injecting saline into the vitreous as an adjunct to diathermy operations for retinal detachment Am J Ophthalmol 31 1948 299 303
60. G.G. Giordano, and M.F. Refojo Silicone oils as vitreous substitutes Prog Polym Sci 23 1998 509 532
61. J.D. Scott The treatment of massive vitreous retraction by the separation of preretinal membranes using liquid silicone Mod Probl Ophthalmol 15 1975 285 290
62. P.A. Cibis, B. Becker, E. Okun, and S. Canaan The use of liquid silicone in retinal detachment surgery Arch Ophthalmol 68 1962 590 599
63. F. Ando Intraocular hypertension resulting from substitute block by silicone oil Am J Ophthalmol 99 1985 87 88
64. W.H. Beekhuis, F. Ando, R. Zivojnovic, D.A. Mertens, and E. Peperkamp Basal iridectomy at 6 o'clock in the aphakic eye treated with silicone oil: prevention of keratopathy and secondary glaucoma Br J Ophthalmol 71 1987 197 200
65. S.A. Madreperla, and B.W. McCuen Inferior peripheral iridectomy in patients receiving silicone oil. Rates of postoperative closure and effect on oil position Retina 15 1995 87 90
66. R.H.B. Grey, and P.K. Leaver Silicone oil in the treatment of massive preretinal retraction. I. Results in 105 eyes Br J Ophthalmol 63 1979 355 360
67. P.K. Leaver, R.H. Grey, and A. Garner Silicone oil injection in the treatment of massive preretinal retraction. II. Late complications in 93 eyes Br J Ophthalmol 63 1979 361 367
68. P.K. Leaver, R.J. Cooling, E.B. Feretis, J.S. Lean, and D. McLeod Vitrectomy and fluid/silicone-oil exchange for giant retinal tears: results at six months Br J Ophthalmol 68 1984 432 438
69. M. Gonvers Temporary silicone oil tamponade in the management of retinal detachment with proliferative vitreoretinopathy Am J Ophthalmol 100 1985 239 245
70. F. Ando, Y. Miyake, K. Oshima, and A. Yamanaka Temporary use of intraocular silicone oil in the treatment of complicated retinal detachment Graefes Arch Clin Exp Ophthalmol 224 1986 32 33
71. B.W. McCuen, M.B. Landers, and R. Machemer The use of silicone oil following failed vitrectomy for retinal detachment with advanced proliferative vitreoretinopathy Graefes Arch Clin Exp Ophthalmol 224 1986 38 39
72. M.S. Cox, M.T. Trese, and P.L. Murphy Silicone oil for advanced proliferative vitreoretinopathy Ophthalmology 93 1986 646 650
73. B.M. Glaser Treatment of giant retinal tears combined with proliferative vitreoretinopathy Ophthalmology 93 1986 1193 1197
74. D. McLeod Silicone-oil injection during closed microsurgery for diabetic traction retinal detachment Graefes Arch Clin Exp Ophthalmol 224 1986 55 59
75. J.S. Rinkoff, E. De Juan, and B.W. McCuen Silicone oil for retinal detachment with advanced proliferative vitreoretinopathy following failed vitrectomy for proliferative diabetic retinopathy Am J Ophthalmol 101 1986 181 186
76. K.H. Lucke, M.H. Foerster, and H. Laqua Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments Am J Ophthalmol 104 1987 624 633
77. J.H. Yeo, B.M. Glaser, and R.G. Michels Silicone oil in the treatment of complicated retinal detachments Ophthalmology 94 1987 1109 1113
78. C.H. Sell, B.W. McCuen, M.B. Landers, and R. Machemer Long-term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy Am J Ophthalmol 103 1987 24 28
79. M. Gonvers Temporary silicone oil tamponade in the treatment of complicated diabetic retinal detachment Graefes Arch Clin Exp Ophthalmol 228 1990 415 422
80. S. Wolf, V. Schon, P. Meier, and P. Wiedemann Silicone oil-RMN3 mixture ("heavy silicon oil") as internal tamponade for complicated retinal detachment Retina 23 2003 335 342
81. H. Er Primary heavy silicone oil usage in inferior rhegmatogenous retinal detachment Ophthalmologica 224 2010 122 125
82. H. Lewis, and T.M. Aarberg Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy Am J Ophthalmol 111 1991 15 19
83. J. Orellana, S.A. Teich, R.M. Lieberman, S. Restrepo, and R. Peairs Treatment of retinal detachments in patients with the acquired immune deficiency syndrome Ophthalmology 98 1991 939 943
84. A. Irvine, L. Lonn, D. Schwartz, M. Zarbin, F. Ballesteros, and S. Kroll Retinal detachment in AIDS: long term results after repair with silicone oil Br J Ophthalmol 81 1997 180 183
85. K. Heimann, B. Dahl, S. Dimopoulos, and K.D. Lemmen Pars plana vitrectomy and silicone oil injection in proliferative diabetic retinopathy Graefes Arch Clin Exp Ophthalmol 227 1989 152 156
86. J.L. Federman, and R.C. Eagle Extensive peripheral retinectomy combined with posterior 360 degrees retinotomy for retinal reattachment in advanced proliferative vitreoretinopathy cases Ophthalmology 97 1990 1305 1320
87. J.L. Federman, and H.D. Schubert Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery Ophthalmology 95 1988 870 876
88. D. Borislav Cataract after silicone oil implantation Doc Ophthalmol 83 1993 79 82
89. J.B. Jonas, H.L.J. Knorr, R.M. Rank, and V.M. Budde Retinal redetachment after removal of intraocular silicone oil tamponade Br J Ophthalmol 85 2001 1203 1207
90. J.C. Pastor, J.M. Zarco, M.J. Delnozal, A. Pampliega, and P. Marinero Clinical consequences of the use of highly purified silicone oil - comparative study of highly and less purified silicone oil Eur J Ophthalmol 8 1998 179 183
91. A. Ohira, C.A. Wilson, E. De Juan, Y. Murata, T. Soji, and K. Oshima Experimental retinal tolerance to emulsified silicone oil Retina 11 1991 259 265
92. P. Versura, M. Cellini, A. Torreggiani, B. Bernabini, A. Rossi, and M. Moretti The biocompatibility of silicone, fluorosilicone and perfluorocarbon liquids as vitreous tamponades Ophthalmologica 215 2001 276 283
93. C.M. Gremillion, G.A. Peyman, M.S. Chen, and K.B. Chang Fluorosilicone oil in the treatment of retinal detachment Br J Ophthalmol 74 1990 643 646
94. S. Yamamoto, and S. Takeuchi Silicone oil and fluorosilicone Semin Ophthalmol 15 2000 15 24
95. M. Doi, and M.F. Refojo Histopathology of rabbit eyes with intravitreous silicone-fluorosilicone copolymer Exp Eye Res 59 1994 737 746
96. M. Doi, and M.F. Refojo Histopathology of rabbit eyes with silicone-fluorosilicone copolymer oil as 6 month internal retinal tamponade Exp Eye Res 61 1995 469 478
97. J.J. Araiz, M.F. Refojo, M.H. Arroyo, F.L. Leong, D.M. Albert, and F.I. Tolentino Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy Invest Ophthalmol Vis Sci 34 1993 522 530
98. J.P. Dailey, J.P. Philips, C. Li, and J.S. Riffle Synthesis of silicone magnetic fluid for use in eye surgery J Magn Magn Mater 194 1999 140 148
99. K. Miyamoto, M.F. Refojo, F.I. Tolentino, G.A. Fournier, and D.M. Albert Perfluoroether liquid as a long-term vitreous substitute. An experimental study Retina 4 1984 264 268
100. S. Chang, N.J. Zimmerman, T. Iwamoto, R. Ortiz, and D. Faris Experimental vitreous replacement with perfluorotributylamine Am J Ophthalmol 103 1987 29 37
101. S. Chang, E. Ozmert, and N.J. Zimmerman Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy Am J Ophthalmol 106 1988 668 674
102. U. Stolba, S. Binder, M. Velikay, P. Datlinger, and A. Wedrich Use of perfluorocarbon liquids in proliferative retinopathy: results and complications Br J Ophthalmol 59 1995 1106 1110
103. A. Loewenstein, M.S. Humaryun, E. De Juan, P.A. Campochiaro Jr., and J.A. Haller Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreopreretinal surgery Ophthalmology 107 2000 1078 1082
104. I.U. Scott, H.W. Flynn Jr., T.G. Murray, and V.J. Fewer Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study Am J Ophthalmol 136 2003 454 463
105. J.A. Schulman, G.A. Peyman, K.J. Blinder, W.A. Alturki, U.R. Desai, and N.C. Nelson Jr. Management of giant retinal tears with perfluoroperhydrophenanthrene (Vitreon) Jpn J Ophthalmol 37 1993 70 77
106. D. Ie, B.M. Glaser, R.N. Sjaarda, J.T. Thompson, L.E. Steinberg, and L.W. Gordon The use of perfluoro-n-octane in the management of giant retinal tears without proliferative vitreoretinopathy Retina 14 1994 323 328
107. I.U. Scott, T.G. Murray, H.W. Flynn Jr., W.J. Feuer, and J.C. Schiffman Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane Ophthalmology 109 2002 1828 1833
108. R. Itoh, T. Ijeda, H. Sawa, K. Kulzumi, T. Yasuhara, and Y. Yamamoto The use of perfluorocarbon liquids in diabetic vitrectomy Ophthalmic Surg Lasers 30 1999 672 675
109. Y. Imamura, M. Minami, M. Ueki, B. Satoh, and T. Ikeda Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy Br J Ophthalmol 87 2003 563 566
110. F. Bottoni, M. Sborgia, P. Arpa, N. De Casa, E. Bertazzi, and M. Monticelli Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment Graefes Arch Clin Exp Ophthalmol 231 1993 619 628
111. M. Rofail, and L.R. Lee Perfluoro-n-octane as a postoperative vitreoretinal tamponade in the management of giant retinal tears Retina 25 2005 897 901
112. U.R. Desai, G.A. Peyman, C.J. Chen, N.C. Nelson, W.A. Alturki, and K.J. Blinder Use of perfluoroperhydrophenanthrene in the management of suprachoroidal hemorrhages Ophthalmology 99 1992 1542 1547
113. M. Flores-Aguilar Intraocular tolerance of perflurooctylbromide (perflubrom) Retina 15 1995 3 13
114. M.D. Conway, G.A. Peyman, M. Karacorlu, N. Bhatt, K.F. Soike, and L.C. Clark Jr. Perflurooctylbromide (PFOB) as a vitreous substitute in non-human primates Int Ophthalmol 17 1993 259 264
115. H. Moreira, J.M. De Queiroz, P.E. Liggett Jr., and P.J. McDonnell Corneal toxicity study of two perfluorocarbon liquids in rabbit eyes Cornea 11 1992 376 379
116. R.E. Foster, W.S. Smiddy, E.C. Alfonso, and R.K. Parrish Secondary glaucoma associated with retained perfluorophenanthrene Am J Ophthalmol 118 1994 253 255
117. C. Batman, and O. Cekic Effect of the long-term use of perfluoroperhydrophenenthrene on the retina Ophthalmic Surg Lasers 29 1998 144 146
118. J.M. De Queiroz, J.C. Blanks Jr., S.A. Ozler, D.V. Alfaro, and P.E. Liggett Subretinal perfluorocarbon liquids: an experimental study Retina 12 1992 33 39
119. G.A. Lee, S.J. Finnegan, and R.D. Bourke Subretinal perfluorodecalin toxicity Aust N Z Ophthalmol 26 1998 57 60
120. G. Lesnoni, T. Rossi, and A. Gelso Subfoveal liquid perfluorocarbon Retina 24 2004 172 176
121. E. Garcia-Valenzuela, Y. Ito, and G.W. Abrams Risk factors for retention of subretinal perfluorocarbon liquid in vitreoretinal surgery Retina 24 2004 746 752
122. G.A. Peyman, J.A. Schulman, and B. Sullivan Perfluorocarbon liquids in ophthalmology Surv Ophthalmol 39 1995 375 395
123. D. Weinberger, N. Goldenberg-Cohen, R. Axer-Siegel, D.D. Gaton, and Y. Yassur Long-term follow-up of perfluorocarbon liquid in the anterior chamber Retina 18 1998 233 237
124. D. Zeana, J. Becker, R. Kuckelkorn, and B. Kirchhof Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution Int Ophthalmol 23 1999 17 24
125. D. Wong, and N. Lois Perfluorocarbons and semifluorinated alkanes Semin Ophthalmol 15 2000 25 35
126. H. Meinert, and T. Roy Semifluorinated alkanes - a new class of compounds with outstanding properties for use in ophthalmology Eur J Ophthalmol 10 2000 189 197
127. K. Kobuch, D.H. Menz, H. Hoerauf, J. Dresp, and V.P. Gabel New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon liquids in vitreoretinal surgery Graefes Arch Clin Exp Ophthalmol 239 2001 635 642
128. J. Roider, H. Hoerauf, K. Kobuch, and V.P. Gabel Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their olygomers) in complicated retinal detachment surgery Graefes Arch Clin Exp Ophthalmol 240 2002 965 971
129. J.B. Jonas, and M. Jger Perfluorohexyloctane endotamponade for treatment of persisting macular hole Eur J Ophthalmol 13 2003 103 104
130. B. Kirchhof, D. Wong, J. Van Meurs, R.D. Hilgers, M. Macek, and N. Lois Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery Am J Ophthalmol 133 2002 95 101
131. M.R. Romano, T. Stappler, J. Marticorena, C. Groenewald, I. Pearce, and S.K. Gibran Primary vitrectomy with Densiron-68 for rhegmatogenous retinal detachment Graefes Arch Clin Exp Ophthalmol 246 2008 1541 1546
132. A. Lappas, A.M.H. Foerster, and B. Kirchhof Use of heavy silicone oil (Densiron-68®) in the treatment of persistent macular holes Acta Ophthalmol 87 2009 866 870
133. D. Wong, J.C. Van Meurs, T. Stappler, C. Groenewald, I.A. Pearce, and J.N. McGalliard A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent Br J Ophthalmol 89 2005 662 665
134. S. Auriol, V. Pagot-Mathis, L. Mahieu, C. Lemoine, and A. Mathis Efficacy and safety of heavy silicone oil Densiron 68 in the treatment of complicated retinal detachment with large inferior retinectomy Graefes Arch Clin Exp Ophthalmol 246 2008 1383 1389
135. W. Li, J. Zheng, Q. Zheng, R. Wu, X. Wang, and M. Xu Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment Eye 24 2010 21 28
136. S. Rizzo, F. Genovesi-Ebert, A. Vento, F. Cresti, E. Di Bartolo, and C. Belting A new heavy silicone oil (HWS 46-3000) used as a prolonged internal tamponade agent in complicated vitreoretinal surgery: a pilot study Retina 27 2007 613 620
137. W.W. Lai, D. Wong, K.K. Li, and P.L. Leow Emulsification and inverted hypopyon formation of oxane HD in the anterior chamber Graefes Arch Clin Exp Ophthalmol 246 2008 1633 1635
138. L. Wickham, P. Tranos, P. Hiscott, and D. Charteris The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery Graefes Arch Clin Exp Ophthalmol 248 2010 1225 1231
139. Q. Meng, S. Zhang, H. Cheng, X. Chen, and Y. Jin Long-term outcomes of Oxane HD as iontraocular tamponade in the treatment of complicated retinal detachments Graefes Arch Clin Exp Ophthalmol 248 2010 1091 1096
140. H. Heimann, T. Stappler, and D. Wong Heavy tamponade 1: a review of indications, use, and complications Eye 22 2008 1342 1359
141. J. Mackiewicz In vivo retinal tolerance of various heavy silicone oils Invest Ophthalmol Vis Sci 48 2007 1873 1883
142. A. Caramoy, S. Schroder, S. Fauser, and B. Kirchhof In vitro emulsification assessment of new silicone oils Br J Ophthalmol 94 2010 509 512
143. M.J. Colthurst, R.L. Willimas, P.S. Hiscott, and I. Grierson Biomaterials used in the posterior segment of the eye Biomaterials 21 2000 649 665
144. F. Baino The use of polymers in the treatment of retinal detachment: current trends and future perspectives Polymers 2 2010 286 322
145. K. Hruby Hyaluronic acid as vitreous body substitute in retinal detachment Klein Monastbl Augenheilkd 138 1961 484 496
146. R.C. Pruett, C.L. Schepens, and D.A. Swann Hyaluronic acid vitreous substitute: a six-year clinical evaluation Arch Ophthalmol 97 1979 2325 2330
147. J.A. Oosterhuis, N.J. Van Haeringen, I.G. Jeltes, and E. Glasius Polygeline as vitreous substitute: I. Observations in rabbits Arch Ophthalmol 76 1966 258 265
148. J.A. Oosterhuis Polygeline as a vitreous substitute: II. Clinical results Arch Ophthalmol 76 1966 374 377
149. K.H. Stenzel, M.W. Dunn, A.L. Rubin, and T. Miyata Collagen gels: design for a vitreous replacement Science 164 1969 1282 1283
150. M.W. Dunn, K.H. Stenzel, A.L. Rubin, and T. Miyata Collagen implants in the vitreous Arch Ophthalmol 82 1969 840 844
151. R.C. Pruett, G.A. Calabria, and C.L. Schepens Collagen vitreous substitute: I. Experimental study Arch Ophthalmol 88 1972 540 543
152. R.C. Pruett, C.L. Schepens, and H.M. Freeman Collagen vitreous substitute: II. Preliminary clinical trials Arch Ophthalmol 91 1974 29 32
153. M. Nakagawa, M. Tanaka, and T. Miyata Evaluation of collagen gel and hyaluronic acid as vitreous substitutes Ophthalmic Res 29 1997 409 420
154. C.P. Liang, G.A. Peyman, P. Serracarbassa, N. Calixto, A.A. Chow, and P. Rao An evaluation of methylated collagen as a substitute for vitreous and aqueous humour Int Ophthalmol 22 1998 13 18
155. E.A. Balazs, and D.B. Sweeney The replacement of the vitreous body in the monkey by reconstituted vitreous and by hyaluronic acid Bibl Ophthalmol 70 1966 230 232
156. S. Suri, and R. Banerjee In vitro evaluation of in situ gels as short term vitreous substitutes J Biomed Mater Res A 79 2006 650 664
157. M. Kishimoto, U. Yamanouchi, S. Mori, and F. Nakamori Experimental study on the substitute of the vitreous body Nippon Ganka Gakkai Zasshi 68 1964 1145 1158
158. G.M. Gombos, and E.R. Berman Chemical and clinical observation on the fate of various vitreous substitutes Acta Ophthalmol 45 1967 794 804
159. G. Scuderi Experimental research on transplantation of the vitreous (attempts of partial substitution with homogenous vitreous, with heterologous fluid, with solutions of polyvinylpyrrolidone) Ann Ottalmol Clin Ocul 80 1954 213 220
160. S. Hayano, and T. Yoshino Local application of polyvinylpyrrolidone (PVP) for some ocular diseases Rinsho Ganka 13 1959 449 453
161. Y. Hong, T.V. Chirila, S. Vijayasekaran, P.D. Dalton, S.G. Tahija, and M.H. Cuypers Crosslinked poly(1-vinyl-2-pyrrolidinone) as a vitreous substitute J Biomed Mater Res 30 1996 441 448
162. Y. Hong, T.V. Chirila, M.J.H. Cuypers, and I.J. Constable Polymers of 1-vinyl-2-pyrrolidinone as potential vitreous substitutes: physical selection J Biomater Appl 11 1996 135 181
163. Y. Hong, T.V. Chirila, S. Vijaysekaran, W. Shen, X. Lou, and P.D. Dalton Biodegradation in vitro and retention in the rabbit eye of crosslinked poly(1-vinyl-2-pyrrolidinone) hydrogel as a vitreous substitute J Biomed Mater Res 39 1998 650 659
164. T.V. Chirila, and Y. Hong Poly(1-vinyl-2-pyrrolidinone) hydrogels as vitreous substitutes: a rheological study Polym Int 46 1998 183 195
165. P.D. Dalton, T.V. Chirila, Y. Hong, and A. Jefferson Oscillary shear experiments as criteria for potential vitreous substitutes Polym Gels Netw 3 1995 429 444
166. K. Muller-Jensen, and H. Kohler An attempt to replace the vitreous body by polyacrylamide Ber Zusammenkunft Dtsch Ophthalmol Ges 68 1968 181 184
167. K. Muller-Jensen Polyacrylamide as an alloplastic vitreous implant Graefes Arch Klin Exp Ophthalmol 189 1974 147 158
168. M.F. Refojo, and H. Zauberman Optical properties of gels designed for vitreous implantation Invest Ophthalmol 12 1973 465 467
169. H.A. Aliyar, W.J. Foster, P.D. Hamilton, and N. Ravi Towards the development of an artificial human vitreous Polym Prep 45 2004 469 470
170. P.D. Hamilton, H.A. Aliyar, and N. Ravi Biocompatibility of thiol-containing polyacrylamide polymers suitable for ophthalmic applications Polym Prep 45 2004 495 496
171. K.E. Swindle, P.D. Hamilton, and N. Ravi Advancements in the development of artificial vitreous humour utilizing polyacrylamide copolymers with disulfide crosslinkers Polym Prep 47 2006 59 60
172. W.J. Foster, H.A. Aliyar, P. Hamilton, and N. Ravi Internal osmotic pressure as a mechanism of retinal attachment in a vitreous substitute J Bioactive Compatible Polym 21 2006 221 235
173. K.E. Swindle, P.D. Hamilton, and N. Ravi In situ formation of hydrogels as vitreous substitutes: viscoelastic comparison to porcine vitreous J Biomed Mater Res A 87 2008 656 665
174. S. Daniele, M.F. Refojo, C.L. Schepens, and H.M. Freeman Glyceryl methacrylate hydrogel as a vitreous implant Arch Ophthalmol 80 1968 120 127
175. T.E. Hogen-Esch, K.R. Shah, and C.R. Fitzgerald Development of injectable poly(glyceryl methacrylate) hydrogels for vitreous prosthesis J Biomed Mater Res 10 1976 975 976
176. M.F. Refojo Polymers in ophthalmic surgery J Biomed Mater Res 5 1971 113 119
177. I.L. Chan, F.I. Tolentino, M.F. Refojo, G. Fournier, and D.M. Albert Vitreous substitute: experimental studies and review Retina 4 1984 51 59
178. J. Fernandez-Vigo, S.A.D. Rey, A. Concheiro, and M. Martinez Molecular weight dependence of the pharmacokinetic of hydroxypropyl methylcellulose in the vitreous J Ocul Pharmacol 6 1990 137 142
179. J. Fernandez-Vigo, M.F. Refojo, and T. Verstraeten Evaluation of a viscoelastic solution of hydroxypropyl methylcellulose as a potential vitreous substitute Retina 10 1990 148 152
180. I.R. Schmolka Artificial skin. I. Preparation and properties of Pluronic F127 gels for the treatment of burns J Biomed Mater Res 6 1972 571 582
181. F.H. Davidorf, R.B. Chambers, O.W. Kwon, W. Doyle, P. Gresak, and S.G. Frank Ocular toxicity of vitreal pluronic polyol F-127 Retina 10 1990 297 300
182. W. Benlian, J. Zhang, and W. Huibin The development of synthetic vitreous body and its experiment in rabbits H. Feng, Y. Han, L. Huang, Polymers and biomaterials 1991 Elsevier Scientific Publishers Amsterdam 397 400
183. A. Yamauchi Synthetic vitreous body of PVA hydrogel D. De Rossi, K. Kajiwara, Y. Osada, A. Yamauchi, Polymer gels - fundamentals and biomedical applications 1991 Plenum Press New York 127 134
184. S. Maruoka Biocompatibility of polyvinylalcohol gel as a vitreous substitute Curr Eye Res 31 2006 599 606
185. G. Leone, M. Consumi, M. Aggravi, A. Donati, S. Lamponi, and A. Magnani PVA/STMP based hydrogels as potential substitutes of human vitreous J Mater Sci Mater Med 21 2010 2491 2500
186. G.A. Peyman, M.D. Conway, and M. Karacorlu Evaluation of silicone gel as a long-term vitreous substitute in nonhuman-primates Ophthalmic Surg Lasers 23 1992 811 817
187. T.V. Chirila Synthetic hydrogel as an artificial vitreous body. A one year animal study of its effects on the retina Cells Mater 5 1995 83 96
188. C. De Jong, E. Bali, J. Libert, and L. Caspers-Velu Adcon-L hydrogel as a vitreous substitute: preliminary results Bull Soc Belge Ophthalmol 278 2000 71 75
189. F. Cavalieri, F. Miano, P. D'Antona, and G. Paradossi Study of gelling behaviour of poly(vinyl alcohol)-methacrylate for potential utilizations in tissue replacement and drug delivery Biomacromolecules 5 2004 2439 2446
190. N.E. Larsen, C.T. Pollak, K. Reiner, E. Leshchiner, and E.A. Balazs Hylan gel biomaterial: dermal and immunologic compatibility J Biomed Mater Res 27 1993 1129 1134
191. Su WY, Chen KH, Chen YC, Lee YH, Tseng CL, Lin FH. An injectable oxidated hyaluronic acid/adipic acid dihydrazide hydrogel as a vitreous substitute. J Biomater Sci Polym Ed, in press. doi:10.1163/092050610X522729.
192. J.Y. Lai Biocompatibility of chemically cross-linked gelatine hydrogels for ophthalmic use J Mater Sci: Mater Med 21 2010 1899 1911
193. ISO 10993-5. Biological evaluation of medical devices. Part 5: Tests for cytotoxicity: In vitro methods.